Roche Holding AG (NEO:ROG)

Canada flag Canada · Delayed Price · Currency is CAD
20.54
0.00 (0.00%)
Jul 25, 2025, 4:00 PM EDT
Market Cap383.42B
Revenue (ttm)108.88B
Net Income (ttm)16.17B
Shares Outn/a
EPS (ttm)20.14
PE Ratio23.71
Forward PE13.84
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume1,766
Open20.54
Previous Close20.54
Day's Range20.54 - 20.54
52-Week Range18.42 - 24.41
Betan/a
RSI54.61
Earnings DateJul 24, 2025

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn... [Read more]

Sector Healthcare
Founded 1896
Employees 103,249
Stock Exchange Cboe Canada
Ticker Symbol ROG
Full Company Profile

Financial Performance

In 2024, Roche Holding AG's revenue was 62.40 billion, an increase of 3.23% compared to the previous year's 60.44 billion. Earnings were 8.28 billion, a decrease of -28.01%.

Financial numbers in CHF Financial Statements

News

There is no news available yet.